HINGE HEALTH INC-A (HNGE) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:HNGE • US4333131039

33.07 USD
-2.16 (-6.13%)
At close: Feb 3, 2026
32.18 USD
-0.89 (-2.69%)
After Hours: 2/3/2026, 6:39:12 PM
Fundamental Rating

3

Taking everything into account, HNGE scores 3 out of 10 in our fundamental rating. HNGE was compared to 102 industry peers in the Health Care Providers & Services industry. While HNGE seems to be doing ok healthwise, there are quite some concerns on its profitability. HNGE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • HNGE had negative earnings in the past year.
HNGE Yearly Net Income VS EBIT VS OCF VS FCFHNGE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 -50M -100M

1.2 Ratios

  • The Return On Assets of HNGE (-87.87%) is worse than 90.20% of its industry peers.
  • Looking at the Return On Equity, with a value of -165.85%, HNGE is doing worse than 76.47% of the companies in the same industry.
Industry RankSector Rank
ROA -87.87%
ROE -165.85%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HNGE Yearly ROA, ROE, ROICHNGE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

  • Looking at the Gross Margin, with a value of 77.28%, HNGE belongs to the top of the industry, outperforming 92.16% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for HNGE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HNGE Yearly Profit, Operating, Gross MarginsHNGE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 20 -20 40 -40 60

More info and screens

6

2. Health

2.1 Basic Checks

  • HNGE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • HNGE has about the same amout of shares outstanding than it did 1 year ago.
  • There is no outstanding debt for HNGE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HNGE Yearly Shares OutstandingHNGE Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M
HNGE Yearly Total Debt VS Total AssetsHNGE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 1.55, we must say that HNGE is in the distress zone and has some risk of bankruptcy.
  • HNGE has a worse Altman-Z score (1.55) than 60.78% of its industry peers.
  • There is no outstanding debt for HNGE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.55
ROIC/WACCN/A
WACC8.94%
HNGE Yearly LT Debt VS Equity VS FCFHNGE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • HNGE has a Current Ratio of 1.85. This is a normal value and indicates that HNGE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.85, HNGE is in the better half of the industry, outperforming 74.51% of the companies in the same industry.
  • A Quick Ratio of 1.81 indicates that HNGE should not have too much problems paying its short term obligations.
  • HNGE has a better Quick ratio (1.81) than 73.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.81
HNGE Yearly Current Assets VS Current LiabilitesHNGE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 88.96% over the past year.
  • HNGE shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.37%.
EPS 1Y (TTM)88.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)33.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • HNGE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 84.54% yearly.
  • HNGE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.99% yearly.
EPS Next Y1066.95%
EPS Next 2Y249.03%
EPS Next 3Y144.96%
EPS Next 5Y84.54%
Revenue Next Year49.9%
Revenue Next 2Y35.36%
Revenue Next 3Y28.97%
Revenue Next 5Y24.99%

3.3 Evolution

HNGE Yearly Revenue VS EstimatesHNGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B
HNGE Yearly EPS VS EstimatesHNGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 2031 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

  • HNGE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 21.23, the valuation of HNGE can be described as rather expensive.
  • HNGE's Price/Forward Earnings ratio is in line with the industry average.
  • HNGE is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 25.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 21.23
HNGE Price Earnings VS Forward Price EarningsHNGE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HNGE Per share dataHNGE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

  • HNGE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HNGE's earnings are expected to grow with 144.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y249.03%
EPS Next 3Y144.96%

More info and screens

0

5. Dividend

5.1 Amount

  • HNGE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

HINGE HEALTH INC-A

NYSE:HNGE (2/3/2026, 6:39:12 PM)

After market: 32.18 -0.89 (-2.69%)

33.07

-2.16 (-6.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04
Earnings (Next)02-10
Inst Owners101.65%
Inst Owner Change5.12%
Ins Owners5.33%
Ins Owner Change-14.72%
Market Cap2.60B
Revenue(TTM)807.54M
Net Income(TTM)-676.46M
Analysts82.86
Price Target64.6 (95.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)397.95%
Min EPS beat(2)92.15%
Max EPS beat(2)703.75%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.58%
Min Revenue beat(2)6.37%
Max Revenue beat(2)8.79%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.48%
PT rev (3m)-0.6%
EPS NQ rev (1m)-1.57%
EPS NQ rev (3m)61.98%
EPS NY rev (1m)70.42%
EPS NY rev (3m)148.65%
Revenue NQ rev (1m)0.4%
Revenue NQ rev (3m)7.68%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)4.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.23
P/S 3.22
P/FCF N/A
P/OCF N/A
P/B 6.38
P/tB 7.63
EV/EBITDA N/A
EPS(TTM)-14.4
EYN/A
EPS(NY)1.56
Fwd EY4.71%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.26
BVpS5.18
TBVpS4.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -87.87%
ROE -165.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.28%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.81
Altman-Z 1.55
F-ScoreN/A
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y1066.95%
EPS Next 2Y249.03%
EPS Next 3Y144.96%
EPS Next 5Y84.54%
Revenue 1Y (TTM)33.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year49.9%
Revenue Next 2Y35.36%
Revenue Next 3Y28.97%
Revenue Next 5Y24.99%
EBIT growth 1Y81.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year569.65%
EBIT Next 3Y115.07%
EBIT Next 5Y71.84%
FCF growth 1Y166.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y176.68%
OCF growth 3YN/A
OCF growth 5YN/A

HINGE HEALTH INC-A / HNGE FAQ

What is the fundamental rating for HNGE stock?

ChartMill assigns a fundamental rating of 3 / 10 to HNGE.


What is the valuation status of HINGE HEALTH INC-A (HNGE) stock?

ChartMill assigns a valuation rating of 2 / 10 to HINGE HEALTH INC-A (HNGE). This can be considered as Overvalued.


What is the profitability of HNGE stock?

HINGE HEALTH INC-A (HNGE) has a profitability rating of 1 / 10.